Finished
Robotic Walking Device to Improve Mobility in Parkinson's Disease
NCT03751371 · Ohio State University · Updated 18 June 2023
- What is being tested
- Training with HWA device; Usual Care
- For
- Parkinson Disease
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 50 years to 80 years. About 45 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 15 May 2019, ends 27 Sept 2021. Registered 23 Nov 2018.
- Results
- Posted on the registry on 18 June 2023.
In the researchers' words
This Phase II randomized controlled trial proposes to examine the impact of long-term use of a novel light-weight and wearable assistive robotic device, called the Honda Walking Assist (HWA) device, to improve mobility in the home and community in individuals with mild to moderate Parkinson's disease (PD). Specific aims of the project are to: 1) determine the short-term impact of mechanical gait assistance on efficiency and ease of walking in individuals with PD, and 2) determine the effect of long-term HWA device usage on the ease and ability to walk unassisted in the home and community in individuals with PD.
Sites
- The Ohio State UniversityColumbus, Ohio, United States